Dey's Medical Stores (Manufacturing)
Kolkata maker of the Keo Karpin hair-oil brand and pharmaceutical formulations, quoted at ₹400 on a tiny 8.5 lakh-share base.
Market cap
₹34.05 Cr
0.09 Cr shares
P/E ratio
8.30
Sector average 28
Book value
₹679.63
P/B 0.59
1-year return
+0.00%
52w ₹400 – ₹400
Currently 0% of the way through its 52-week range.
Indicative price history
1Y change
+0.00% ₹400 → ₹400
52-week band in this window: ₹400.00 – ₹400.00. Weekly indicative marks, not exchange-traded prices.
Key highlights
- Owner of the Keo Karpin hair-oil brand and a broad formulation range.
- Paid-up capital ₹85 lakh; about 8.5 lakh shares of ₹10.
- Dealer quote ₹400 values the company near ₹34 Cr.
About Dey's Medical
Dey's Medical Stores (Manufacturing) Ltd, incorporated in August 1957, is the manufacturing arm of Kolkata's Dey's Medical group. It produces pharmaceutical formulations — antibiotics, gastro-intestinal, ophthalmic and other therapeutic products — alongside consumer-health brands, the best known being Keo Karpin hair oil, which has been sold across eastern India for decades.
Tofler places operating revenue in the ₹100–500 Cr band for FY23 with EBITDA down about 70% that year; the group's retail and distribution sister company, Dey's Medical Stores Pvt Ltd, separately reported ₹256 Cr of revenue in FY24. Paid-up capital is only ₹85.12 lakh against authorised capital of ₹5 Cr.
With a ₹10 face value and about 8.5 lakh shares, the ₹400 dealer quote on wwipl.com values the company at roughly ₹34 Cr — a small fraction of annual sales, reflecting thin profitability and very limited float.
Figures preliminary; verify from MCA filings. Revenue, profit and balance-sheet lines below are estimates built from registry ranges.
Where the revenue comes from
- Pharmaceutical formulations60%
Antibiotics, GI, ophthalmic and other prescription products
- Consumer health (Keo Karpin and others)35%
Hair oil and OTC personal-care lines
- Other5%
Contract manufacturing and miscellaneous
Products & services
Keo Karpin
Non-sticky hair oil sold across eastern and northern India
Prescription formulations
Antibiotics, gastro-intestinal and ophthalmic products
What works
- • Heritage consumer brand (Keo Karpin) with strong recall in eastern India.
- • Diversified formulation portfolio spanning prescription and OTC products.
- • Market value (~₹34 Cr) is a small fraction of annual revenue.
What to watch
- • EBITDA fell about 70% in FY23; profitability is thin and volatile.
- • Only 8.5 lakh shares exist and most sit with the Dey family — trades are rare and spreads wide.
- • Related-party structure with Dey's Medical Stores Pvt Ltd (retail) makes standalone economics hard to read.
- • All financial figures on this page are preliminary estimates.
Compare with peers
| Company | Price | Market cap | P/E | P/B | Rev CAGR |
|---|---|---|---|---|---|
| Dey's MedicalThis page | ₹400.00 | ₹34.05 Cr | 8.30 | 0.59 | +6.90% |
| East India Pharma | ₹39.00 | ₹26.01 Cr | 5.91 | 0.43 | +7.88% |
| Martin & Harris | ₹959.00 | ₹479.5 Cr | 11.99 | 1.88 | +9.92% |
Latest reported year: FY25 ending 31 Mar 2025.